An Overview of Protein-Bound Paclitaxel Uses
- For metastatic breast cancer (cancer that has spread to other parts of the body) that has failed to respond to other chemotherapy medications.
- For breast cancer that has returned within six months of adjuvant chemotherapy (chemotherapy after breast cancer surgery).
How Does Protein-Bound Paclitaxel Work?
Protein-bound paclitaxel is part of a group of medications called taxanes. These medicines stop cancer cells from growing and multiplying by interfering with certain structures in the cell.
While protein-bound paclitaxel can kill both healthy and cancerous cells, it has a greater effect on cells that are multiplying rapidly. Generally, cancer cells multiply more rapidly than healthy cells and are, therefore, more affected by protein-bound paclitaxel.
Protein-bound paclitaxel is a new form of paclitaxel. Paclitaxel does not dissolve well and requires solvents in order to be dissolved and injected. These solvents can cause irritation and allergic reactions. Protein-bound paclitaxel is a new form of paclitaxel that is, as the name implies, bound to albumin (a protein normally found in the body). Paclitaxel that is bound to albumin dissolves more easily, and solvents are not needed. This makes protein-bound paclitaxel much less irritating than solvent-based paclitaxel. It also means that protein-bound paclitaxel can be injected more quickly than solvent-based paclitaxel.